Thirteen Deaths Now Blamed On Medtronic’s Recalled Fidelis ICD Leads
This article was originally published in The Gray Sheet
Executive Summary
Medtronic has added eight patient deaths to the list of those linked to a failure of its recalled Sprint Fidelis implantable cardioverter defibrillator leads, but says the latest adverse event report data does not identify any new or unexpected trends
You may also be interested in...
Senate Dems Argue That Device Safety Act Will Not Curb Innovation
Senate Democrats are challenging the notion that removing federal pre-emption protection for PMA-approved devices, solidified last year by the Supreme Court, will stifle innovation
Senate Dems Argue That Device Safety Act Will Not Curb Innovation
Senate Democrats are challenging the notion that removing federal pre-emption protection for PMA-approved devices, solidified last year by the Supreme Court, will stifle innovation
Cameron Health Set To Sell S-ICD In Europe; U.S. Trial Starts This Quarter
Cameron Health expects to soon launch the S-ICD, an implantable cardioverter defibrillator with subcutaneously-placed leads, at sites in Europe and New Zealand